The UiO:Life Science initiative: why is it important for Oslo - - PowerPoint PPT Presentation

the uio life science initiative why is it important for
SMART_READER_LITE
LIVE PREVIEW

The UiO:Life Science initiative: why is it important for Oslo - - PowerPoint PPT Presentation

The UiO:Life Science initiative: why is it important for Oslo University Hospital? Erlend B. Smeland Director research, innovation and education Future development OUS Improved therapy and research In modern buildings To a growing


slide-1
SLIDE 1

The UiO:Life Science initiative: why is it important for Oslo University Hospital?

Erlend B. Smeland

Director research, innovation and education

slide-2
SLIDE 2

2016:

  • 1290 MAN YEARS IN RESEARCH (INCL. RESEARCH SUPPORT) - APPROXIMATELY 50% EXTERNALLY

FUNDED

  • APPROXIMATELY 1900 ARTICLES

Future development OUS

  • Improved therapy and

research

  • In modern buildings
  • To a growing population

Strengthen research

  • Good and excellent research
slide-3
SLIDE 3

Close research collaboration between OUH and UiO within Life Science

  • Centers/research milieus
  • Infrastructure

– Core facilities – Biobanks and registries

  • Technology and competence

– Data, bioinformatics, computational analysis

  • Studies of disease mechanisms
  • Innovation and commersialiszation

From brilliant individuals to brilliant systems

  • Large centers
  • Large infrastructure
  • Clusters
  • Partnership
slide-4
SLIDE 4

Stab forskning, innovasjon og utdanning

Health research - trends

Technological development

Equipment and data analysis (big data, automation)

Increased biological insight

Development of new diagnostic tools and novel theraphy

slide-5
SLIDE 5

Biobanks and registries

Increased (secure) use and reuse

slide-6
SLIDE 6
  • Unspecific diagnosis and

ineffective treatment for many diseases

  • Adverse effects common

Todays medical practice

slide-7
SLIDE 7

Personalized medicine (Precision medicine)

Stab forskning, innovasjon og utdanning

slide-8
SLIDE 8
slide-9
SLIDE 9

ICT project grants from the Norwegian Research Council

BigMed

Håvard Danielsen Erik Fosse

In silico Pathology - Improving diagnosis by utilizing Big Data and software- driven automation of pathology ICT platform that addresses the analytic bottlenecks for the implementation of precision medicine, and paves the way for novel big data analytics.

slide-10
SLIDE 10

Increased need for novel competence in the health sector

  • Education of health personell
  • Novel positions (bioinformatics,

biostatistics, ICT, computational science, physics)

  • Research and innovation
  • Diagnostic and clinical departments
  • Personalized medicine, technologial development, complex

data- and image analyses

Stab forskning, innovasjon og utdanning

slide-11
SLIDE 11

Stab forskning, innovasjon og utdanning

Health research - trends

Technological development

Disruptive technologies, automation and big data

Increased biological insight

Development of new diagnostic tools and novel theraphy

BIOTECH PHARMA MEDTECH

slide-12
SLIDE 12

Innovation and industrial collaboration

  • OUS/UiO shared TTO: Inven2
  • 2016: 84 patents, 46 licence

agreements and 7 new companies

  • 140 new clinical studies (2016)

“Successful medical schools will be surrounded by clusters of small/medium-size biotech/biomed companies” Hans Wigzell

slide-13
SLIDE 13
slide-14
SLIDE 14

Gaustad-Rikshospitalet

Rikshospitalet

slide-15
SLIDE 15

Alternative development Rikshospitalet

slide-16
SLIDE 16

Correlation between high research quality and hospital performance

US News World report Best hospitals & Best graduate schools report 2010-11

slide-17
SLIDE 17

Oslo Life Science

Universitetet i Oslo Oslo universitetssykehus Oslo kommune Stronger together (from Odd Stokke Gabrielsen)